Omalizumab (Xolair) in children with seasonal allergic rhinitis: leukotriene release as a potential in vitro parameter to monitor therapeutic effects (Q34660055)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Omalizumab (Xolair) in children with seasonal allergic rhinitis: leukotriene release as a potential in vitro parameter to monitor therapeutic effects |
scientific article |
Statements
1 reference
Omalizumab (Xolair) in children with seasonal allergic rhinitis: leukotriene release as a potential in vitro parameter to monitor therapeutic effects (English)
1 reference
Ulrich Wahn
1 reference
Eckard Hamelmann
1 reference
Matthias Volkmar Kopp
1 reference
Stefan Stenglein
1 reference
Wolfgang Kamin
1 reference
Frank Friedrichs
1 reference
Andrea von Berg
1 reference
Stefan Zielen
1 reference
Joachim Kuehr
1 reference
1 September 2007
1 reference
1 reference
18
1 reference
6
1 reference
523-527
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference